Literature DB >> 11400649

Prolonged second response to cisplatin, etoposide, and ifosfamide in a child with a recurrent brainstem glioblastoma.

E Schuller1, R Seidl, C Wandl, K Dieckmann, I Slavc.   

Abstract

The prognosis for patients with malignant brainstem tumors is poor. The authors report on a 6-year-old girl with a biopsy proven pontine glioblastoma, who, after initial chemo-radiotherapy and tumor progression, experienced a prolonged second response to a salvage therapy consisting of cisplatin, etoposide, and ifosfamide. The patient recovered from her life-threatening condition with almost complete resolution of all neurologic deficits paralleled by a dramatic shrinkage of the tumor documented by magnetic resonance imaging.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11400649     DOI: 10.1080/088800101750238559

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  1 in total

1.  Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients.

Authors:  Antonio Silvani; Marica Eoli; Andrea Salmaggi; Elena Lamperti; Elio Maccagnano; Giovanni Broggi; Amerigo Boiardi
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.